Abstract Plain Language Summaries

Pfizer Abstract Plain Language Summaries

At Pfizer, we know that many people actively seek the latest scientific developments related to medicines. Clinical data, however, can be complex and often difficult to understand if you are not a scientist. To help interested non-scientists better understand the latest research, we are developing summaries in plain language for research results presented at medical conferences. We call these “abstract plain language summaries” (APLS).

PLEASE NOTE: The APLS reports represent results of only one study. Researchers must look at the results of many types of studies to understand whether a study drug works, how it works, and whether it is safe to prescribe to patients. The results might be different from the outcome of other studies that researchers have presented in the past. It’s also important to note that these data are investigational, and the treatments may not be approved in these settings by regulatory agencies.

Click the links below to access each APLS for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.